Mino-Lokis our leadassetWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022Mino-WrapOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeNot manycompaniesthis size with2 late stageassetsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityMyron Holubiakand I founded aprivatecompany in2013I/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BInsidersinvested$26.5mI/ONTAKis our leadassetWe haveenough cashto go wellinto 2023I'm ashareholdermyselfAn actualiMSCupdateI won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoidsWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketMino-Lokis our leadassetWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022Mino-WrapOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeNot manycompaniesthis size with2 late stageassetsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityMyron Holubiakand I founded aprivatecompany in2013I/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BInsidersinvested$26.5mI/ONTAKis our leadassetWe haveenough cashto go wellinto 2023I'm ashareholdermyselfAn actualiMSCupdateI won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoidsWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2Bmarket

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Mino-Lok is our lead asset
  2. We had a phase 2b trial with 100% efficacy
  3. Our Halo-Lido trial will have final patient by end of 2022
  4. We intend to submit a BLA in 2H 2022
  5. Mino-Wrap
  6. Only biotech with 2 Myron's on the leadership team
  7. I/ONTAK was the best deal I ever made
  8. Not many companies this size with 2 late stage assets
  9. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  10. We will have exclusivity
  11. Myron Holubiak and I founded a private company in 2013
  12. I/ONTAK's potential market is >$300m
  13. Mino-Lok potential market >$1B
  14. Insiders invested $26.5m
  15. I/ONTAK is our lead asset
  16. We have enough cash to go well into 2023
  17. I'm a shareholder myself
  18. An actual iMSC update
  19. I won't dilute shareholders
  20. We will open up international sites for Mino-Lok trial
  21. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  22. There are no FDA approved drugs to treat hemorrhoids
  23. We expect to finish the Mino-Lok trial this year
  24. Hemorrhoids is a $2B market